Canadian Association of Neuroscience Nurses - CANN Nova Scotia Chapter

01/23/2026

COME ONE, COME ALL — it’s 🧠 Neuro Trivia, y’all!

📍 The Daily Grind – Bishop’s Landing
🕡 6:30 PM
📅 January 23rd

✨ What’s happening:
🧠 Neuro Trivia
🎁 Prizes
🍽️ Catering provided
🎤 Presentations by Dr. Balgees Ajlan + Dr. Rana Moshref

Bring your friends, your coworkers, your smartest neurons— come for the trivia, stay for the vibes. 💥

01/23/2026

🧠

01/20/2026

Join us in the beautiful Bow Valley of the Canadian Rockies for our annual conference. We invite all healthcare professi

01/14/2026

Reminder! Abstract submission deadline is Jan 18th- you have four days left 📝https://cannmore2026.dryfta.com/

01/14/2026

https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fteams.microsoft.com%2Fmeet%2F24229088112935%3Fp%3DJa2romb6M9FTtBGSjc&data=05%7C02%7CEmilyA.Cameron%40nshealth.ca%7Cc2fc1d4e83904da787df08de538a623e%7C8eb23313ce754345a56a297a2412b4db%7C0%7C0%7C639040050979987956%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=06pPLonp5zoFaKfSA6Oays9RG5ecJWBq9BVGEyAr8Cc%3D&reserved=0

01/12/2026

Feeling lucky? Buy a square and support your vibrant neuro community! $10 per square - pick your lucky number for the chance to win $500. Accepting cash or e-transfer to cann.novascotia@gmail.com. Good luck!!! A winner will be drawn when the board is full. Thank you :)
36/100 squares sold!

01/09/2026

Abstract submissions close in 10 days!!!

CANNmore 2026 conference call for abstracts deadline is 10 days away! Need more info? Visit https://cannmore2026.dryfta.com/

01/08/2026

🧠😴 The Migraine Connection: Sleep & Mental Health (Part 1)

Poor sleep can trigger migraine. Migraine can disrupt sleep. Mental health weaves through both.

Join Dr. Michael Mak, MD, FRCPC, FAASM as he explores:
• The role of sleep in migraine
• Common sleep disorders (insomnia, sleep apnea, circadian disruptions)
• The two-way link between migraine and mental health
• Why treating one can help improve the others

📅 Wednesday, January 14
⏰ 7:30 PM ET
🎓 Free webinar | Registration required

Register now: 0e2e0f8f-0435-49d5-a195-4fbac012e1bb@1751f303-4d61-4c06-b925-154ac230edec" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/0e2e0f8f-0435-49d5-a195-4fbac012e1bb@1751f303-4d61-4c06-b925-154ac230edec

11/25/2025

CANNmore 2026 Abstract Submission portal is OPEN! 👏

https://cannmore2026.dryfta.com/72-abstract-submission

The Scientific Committee welcomes the submission of abstracts on any neuroscience nursing topic including: clinical practice, research, education, and policy. Submissions from Allied Health Professionals are also welcomed. This is an excellent opportunity to showcase your work, network with peers, and contribute to the advancement of neuroscience health services.

Conference Topics /Ideas:

Neuro Disorders

Neurocritical Care

Neurorehabilitation

Neuroscience Research (includes student capstone projects, theses, and dissertations)

Quality Improvement Projects

Advanced Practice in Neuroscience Nursing

Emerging Issues in Neuroscience Nursing

Leadership and Professional Development in Neurosciences

Presentation Formats:

Oral Presentation: Plenary (45 minutes+10 minutes for questions)
Oral Presentation: Concurrent Session (20 minutes +5 minutes for questions)

Oral Presentation: Pecha Kucha (6 mins 40 seconds +2 mins for questions)

Workshop (45 to 90 minutes)

Digital Poster (time slots for presentation/Q&A will be determined based on number of submissions)

Creative Arts: Visual media, Dance, Music, Poetry, etc. (5 to 15 minutes)

11/25/2025

11/25/2025

Promising new treatments for multiple sclerosis (MS) are on the horizon - and The Neuro’s Clinical Research Unit is helping bring them closer.

“The majority of patients diagnosed today will live without new attacks or new lesions on their brain or spinal cord. That is very different from a patient’s experience just a decade ago.” – Dr. Adil Harroud, who is leading clinical trials exploring therapies that could ease difficult MS symptoms and improve long-term disease management.

Harroud is currently leading two innovative clinical trials: one testing an eye-tracking app to detect early changes in brain function, and another investigating a novel therapy to ease spasticity, a common and challenging MS symptom.

🧠 Learn more about what’s next in MS research: https://cru.mcgill.ca/advances-ms/
📧 For more information about current trials: https://cru.mcgill.ca/trials/

-------

De nouveaux traitements prometteurs pour la sclérose en plaques (SP) se profilent à l’horizon — et l’Unité de recherche clinique du Neuro () contribue à les rapprocher.

« La majorité des patients diagnostiqués aujourd’hui vivront sans nouvelles poussées ni nouvelles lésions au cerveau ou à la moelle épinière. C’est très différent de l’expérience des patients d’il y a seulement dix ans. » – Dr Adil Harroud, qui dirige des essais cliniques sur des thérapies visant à soulager les symptômes difficiles de la SP et à améliorer la gestion à long terme de la maladie.

Le Dr Harroud mène actuellement deux essais cliniques novateurs : l’un teste une application de suivi oculaire pour détecter précocement des changements dans le fonctionnement du cerveau, et l’autre évalue une nouvelle thérapie visant à réduire la spasticité, un symptôme fréquent et difficile de la SP.

🧠 Pour en savoir plus sur les prochaines avancées de la recherche sur la SP : https://cru.mcgill.ca/fr/avancees-sp/

McGill University McGill Faculty of Medicine and Health Sciences Centre universitaire de santé McGill - McGill University Health Centre MS Canada